共 50 条
Head-to-head: how many categories for grading urothelial carcinoma?
被引:0
|作者:
Varma, Murali
[1
]
Comperat, Eva
[2
]
van der Kwast, Theodorus
[3
]
机构:
[1] Univ Hosp Wales, Dept Cellular Pathol, Heath Pk, Cardiff CF14 4XW, Wales
[2] Med Univ Vienna, Dept Pathol, Vienna, Austria
[3] Univ Toronto, Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
关键词:
tumour grade;
urothelial carcinoma;
WHO;
1973;
2004;
2022;
BLADDER-CANCER;
CLASSIFICATION;
D O I:
10.1111/his.15091
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Tumour grade is a critical prognostic parameter for guiding the management of patients with non-muscle invasive bladder cancer. In 2004, the World Health Organisation (WHO) adopted a binary (low-grade/high-grade) grading system to replace the three-tier (grades 1-3) system used to grade urothelial carcinoma since 1973. However, there is significant global variation in the grading of urothelial carcinoma. Some pathology and clinical guidelines recommend reporting of the WHO 1973 and 2004 grades in parallel, while others require reporting only of the WHO 2004 grade. This variation in pathology practice is clinically significant, because the two grading systems are not readily translatable. Some experts have proposed novel systems for grading urothelial carcinoma that involve splitting of the WHO 1973 and 2004 grade categories. The arguments for and against splitting urothelial carcinomas into two-, three- and four-grade categories are independently discussed by the three authors. Urothelial carcinoma grading is subject to significant global variation. Some guidelines recommend reporting WHO 1973 and WHO grades, while others require reporting only WHO 2004. In this issue, Drs Varma, Comperat and van der Kwast discuss the arguments for and against splitting urothelial carcinomas into two-, three- and four-grade categories.image
引用
收藏
页码:421 / 428
页数:8
相关论文